These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bradykinin potentiation by ACE inhibitors: a matter of metabolism. Tom B, Dendorfer A, de Vries R, Saxena PR, Jan Danser AH. Br J Pharmacol; 2002 Sep; 137(2):276-84. PubMed ID: 12208785 [Abstract] [Full Text] [Related]
3. Protein kinase C and phosphatase inhibitors block the ability of angiotensin I-converting enzyme inhibitors to resensitize the receptor to bradykinin without altering the primary effects of bradykinin. Marcic BM, Erdös EG. J Pharmacol Exp Ther; 2000 Aug; 294(2):605-12. PubMed ID: 10900238 [Abstract] [Full Text] [Related]
4. Enhancement of bradykinin and resensitization of its B2 receptor. Marcic B, Deddish PA, Jackman HL, Erdös EG. Hypertension; 1999 Mar; 33(3):835-43. PubMed ID: 10082496 [Abstract] [Full Text] [Related]
5. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells. Minshall RD, Tan F, Nakamura F, Rabito SF, Becker RP, Marcic B, Erdös EG. Circ Res; 1997 Nov; 81(5):848-56. PubMed ID: 9351459 [Abstract] [Full Text] [Related]